It's a lifesaver.

A newly disclosed security issue in the popular jsPDF library has raised serious concerns for web developers. The flaw could ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

A dynamic invoice generation system built with Node.js and Express. It uses EJS templating for rendering invoice data from JSON and Puppeteer to generate downloadable PDF invoices.

We list the best billing and invoicing software, to make it simple and easy to manage your income and expenses. Even better, many options cost little to use, or are even free for light use. Free ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Gather all account statements for the reconciliation period. Compare bank statement transactions to your internal records. Adjust for outstanding checks and uncleared deposits. Record interest income ...

Leeron is a New York-based writer who specializes in covering technology for small and mid-sized businesses. Her work has been featured in publications including Bankrate, Quartz, the Village Voice, ...

The invoicing System is developed using PHP, CSS, Bootstrap, and JavaScript. Talking about the project, it contains an admin side and a user side from where a user can view total orders which includes ...

AI drug discovery specialist Generate Biomedicines has raised $400 million in the year’s largest initial public offering to date for a biotechnology firm. The company, which was launched in 2018 by ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. 2025 was a slow year for IPOs, with ...